ADVERTISEMENT
ADVERTISEMENT
Mitigating Biopharmaceutical Impurities in Monoclonal Antibody Therapeutic Manufacturing
Host Cell Protein and Impurity Risk Mitigation in Monoclonal Antibody Therapeutic Manufacturing
In this webinar, Andrew Hamilton and Joe Hirano will explore how to detect and remove host cell proteins and other impurities during biologics manufacturing.
Host Cell Protein and Impurity Risk Mitigation in Monoclonal Antibody Therapeutic Manufacturing
Host Cell Protein and Impurity Risk Mitigation in Monoclonal Antibody Therapeutic Manufacturing

In this webinar, Andrew Hamilton and Joe Hirano will explore how to detect and remove host cell proteins and other impurities during biologics manufacturing.

In this webinar, Andrew Hamilton and Joe Hirano will explore how to detect and remove host cell proteins and other impurities during biologics manufacturing.

biologics

How to Speed Up Cell Therapy Development Processes
How to Speed Up Cell Therapy Development Processes
The Scientist | Sep 15, 2023 | 1 min read
In this webinar, Patrick Schmidt will explore how to streamline CAR T cell product manufacturing processes for immunotherapy. 
Discover Solutions for the Challenges of Biotherapeutic Development
Traversing the Biotherapeutic Development Journey
Cytiva | Aug 31, 2023 | 1 min read
Discover tips for guiding drug development from discovery to the clinic.
Discover decision-making solutions for robust, reliable, and high-yielding cell line development
Evading Obstacles in Cell Line Development
Sartorius | Jun 19, 2023 | 1 min read
Researchers need to start with a reliable process for commercial biopharmaceutical production in living cells.
iStock
Targeting the Undruggable
The Scientist | May 8, 2023 | 1 min read
Through a combination of basic science research and clinical trials, researchers uncover innovative approaches for targeted cancer treatment. 
Learn the Key Considerations when Moving into Biomanufacturing
Getting Off to a Good Start When Moving into Biological Manufacturing
Cytiva | Jan 26, 2023 | 1 min read
Discover how a solid initial set-up helps make the transition into biomanufacturing seamless.
Achieve Comprehensive Analysis and Deeper Insight into Complex Biotherapeutics
High-Resolution Mass Spectrometry Solutions in Drug Discovery and Development
SCIEX | Jan 11, 2023 | 1 min read
Electron activated dissociation (EAD) and the Zeno trap provide high sensitivity and certainty in mass spectrometry results.
Discover how counterflow centrifugation streamlines cell therapy workflows
Closed Cell Processing Systems for Cell Therapy Workflows
Thermo Fisher Scientific | Dec 1, 2022 | 1 min read
Closed systems increase cell therapy manufacturing process efficiency.
Achieve Advanced Characterization of Complex Protein Therapeutics
High-Resolution Mass Spectrometry Solutions in Drug Discovery and Development
SCIEX | Oct 25, 2022 | 1 min read
Electron activated dissociation (EAD) and the Zeno trap provide high sensitivity and certainty in mass spectrometry results. 
iStock
A Cleaner Clean Room Starts with the CO2 Incubator
Thermo Fisher Scientific | Aug 15, 2022 | 1 min read
Clean room equipment is a leading source of particulate contamination for cell-based biologics manufacturing.
Discover how innovation boosts clinical manufacturing efficiency
Innovating Cell Therapy
Thermo Fisher Scientific | Aug 8, 2022 | 1 min read
A closed and scalable electroporation system is an example of how innovation can boost clinical manufacturing efficiency.
Learn how to make cell therapy manufacturing workflows more efficient.
Successful Cell Therapy Manufacturing
Thermo Fisher Scientific | Jul 14, 2022 | 1 min read
Explore what makes an effective and efficient cell therapy manufacturing workflow.
Producing Recombinant Proteins with 3-D Cell Culture Systems
Overcoming Recombinant Protein Production Barriers
FiberCell Systems | Mar 10, 2022 | 1 min read
3-D cell culture systems open new possibilities for recombinant protein production.
Multiplexed and Trackable CRISPR-Based Genome Engineering
A Platform for Automated CRISPR-Based Microbial Genome Engineering
Inscripta | Jan 25, 2022 | 1 min read
Discover how you can design and generate genomic edits to optimize heterologous protein expression and activity in E. coli.
Automating Bacterial Plasmid Purification
Automating DNA Extraction for High-Throughput Bacterial Plasmid Purification
Analytik Jena | Jan 19, 2022 | 1 min read
How automated liquid handling accelerates plasmid purification.
Securing the Antibody Supply Chain through Recombinant Antibody Technology: A COVID-19 Case Study
The Scientist Creative Services Team in collaboration with Sartorius Corporation | Mar 29, 2021 | 1 min read
Nicholas Hutchings will discuss how recombinant antibody technology can speed up the response to a pandemic.
Putting the Brakes on SARS-CoV-2: Neutralizing Antibodies
The Scientist | Jul 6, 2020 | 1 min read
Experts will discuss potential neutralizing antibodies currently under investigation for SARS-CoV-2 treatment.
Regulations for Biosimilars
Lisa A. Haile and Kimberly K. Egan | Jun 1, 2012 | 5 min read
As biologic drug patents begin to expire, generic versions will hit the market—but how will they be regulated?
Gene Therapy for Brain Disease
Jef Akst | May 16, 2012 | 2 min read
Delivering a missing enzyme to the brains of paralyzed children with a rare, life-threatening neurological disease restores movement and builds muscle mass.
FDA Eases Sterility Requirements
Bob Grant | May 16, 2012 | 1 min read
The US Food and Drug Administration has relaxed some of the rules governing how companies must test the sterility of materials used to make biologic drugs.
ADVERTISEMENT